Arrowhead Pharmaceuticals Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.07 |
Market Cap |
$2.52 B |
Shares Outstanding |
94.81 M |
Public Float |
81.6 M |
Address |
225 South Lake Avenue Pasadena California 91101 United States |
Employees | - |
Website | http://www.arrowheadpharma.com |
Updated | 07/08/2019 |
Arrowhead Pharmaceuticals, Inc. engages as a biopharmaceutical company developing targeted RNAi therapeutics. Its pipeline includes clinical programs in chronic hepatitis B virus and partner based programs in obesity and oncology. The company was founded by R. |